Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-24-031819
Filing Date
2024-07-01
Accepted
2024-06-28 21:08:55
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 ny20031755x3_424b5.htm 424B5 602011
2 logo_elicio.jpg GRAPHIC 28117
3 logo_eliciox1.jpg GRAPHIC 33082
4 logo_eliciox2.jpg GRAPHIC 56842
5 logo_jones.jpg GRAPHIC 13580
6 logo_jonesx1.jpg GRAPHIC 25551
  Complete submission text file 0001140361-24-031819.txt   818762
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279925 | Film No.: 241087580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)